Stay updated on Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A footer release/version update was applied on the study page (updating the visible “Revision” number from v3.5.2 to v3.5.3). This reflects a site change rather than an alteration to the clinical trial details.
    Difference
    0.1%
    Check dated 2026-04-24T06:22:31.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:44:04.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Added revision entry v3.5.0 and removed revision entry v3.4.3, affecting only the page's release metadata.
    Difference
    0.1%
    Check dated 2026-03-19T04:56:24.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:24:30.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added and Revision: v3.4.1 removed; the government funding/operating status notice was deleted.
    Difference
    0.4%
    Check dated 2026-02-11T11:38:28.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH operations is now displayed, and the page shows a new revision tag (v3.4.1) replacing the previous v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T10:20:52.000Z thumbnail image

Stay in the know with updates to Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.